Phase 1/2 Study of Nexi-001 Donor-Derived Multi-Antigen Specific CD8+T Cells for the Treatment of Relapsed Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Transplantation

被引：1

作者：

Al Malki, Monzr M. ^{[1
]}

Vasu, Sumithira ^{[2
,3
]}

Modi, Dipenkumar ^{[4
]}

Perales, Miguel-Angel ^{[5
,6
]}

Ghoda, Lucy Y. ^{[7
,8
]}

Bui, Donna ^{[9
]}

Edavana, Vineetha ^{[10
]}

Lu, Emily ^{[10
]}

Kim, Sojung ^{[10
]}

Suarez, Lauren ^{[10
]}

Oelke, Mathias ^{[10
]}

Bednarik, Daniel ^{[10
]}

Knight, Robert D. ^{[11
]}

Varela, Juan C. ^{[12
,13
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA

[2] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH USA

[3] Comprehens Canc Ctr Columbus, Div Hematol, Dept Internal Med, Columbus, OH USA

[4] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Blood & Marrow Stem Cell Transplant Program, Detroit, MI USA

[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[7] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, 1500 E Duarte Rd, Duarte, CA 91010 USA

[8] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol Malignancies Translat Sci, Gehr Family Ctr Leukemia Res, Duarte, CA USA

[9] City Hope Natl Med Ctr, Duarte, CA USA

[10] NexImmune Inc, Gaithersburg, MD USA

[11] NexImmune Inc, Berkeley Hts, NJ USA

[12] Florida Hosp, Blood & Marrow Transplant Ctr, Winter Pk, FL USA

[13] Advent Hlth, Blood & Marrow Transplant Program, Orlando, FL USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-152419

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4819

引用

页数：5

共 50 条

[31] Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress
Krakow, Elizabeth F.
Summers, Corinne
Dahlberg, Ann
Bar, Merav
Biernacki, Melinda Ann
Cunningham, Tanya
Vartanian, Nicole
Hickner, Megan
Chaney, Colette
Habtetsion, Tsadik
Woodward, Kyle
Dossa, Robson
Brault, Michelle
Bleakley, Marie
BLOOD, 2020, 136
[32] Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial
Luo, Yi
Gao, Lei
Liu, Jia
Yang, Luxin
Wang, Lu
Lai, Xiaoyu
Gao, Shichun
Liu, Lizhen
Zhao, Lu
Ye, Yishan
Wang, Manning
Shen, Lianjun
Cao, W. William
Wang, Dongrui
Li, Wenling
Zhang, Xi
Huang, He
ECLINICALMEDICINE, 2024, 67
[33] Infusion Of Donor-Derived CD19-Redirected-Virus-Specific T Cells For B-Cell Malignancies Relapsed After Allogeneic Stem Cell Transplant: A Phase I Study
Cruz, Conrad Russell Y.
Micklethwaite, Kenneth P.
Savoldo, Barbara
Ramos, Carlos A.
Lam, Sharon
Ku, Stephanie
Diouf, Oumar
Liu, Enli
Barrett, A. John
Ito, Sawa
Shpall, Elizabeth J.
Krance, Robert A.
Kamble, Rammurti T.
Carrum, George
Hosing, Chitra M.
Gee, Adrian P.
Mei, Zhuyong
Grilley, Bambi J.
Heslop, Helen E.
Rooney, Cliona M.
Brenner, Malcolm K.
Bollard, Catherine M.
Dotti, Gianpietro
BLOOD, 2013, 122 (21)
[34] Donor-derived cytomegalovirus-specific CD8+ T cells restricted to shared, donor-specific, or host-specific HLA after HLA mismatched hematopoietic stem cell transplantation
Ikegame, Kazuhiro
Fukunaga, Keiko
Osugi, Yuko
Kaida, Katsuji
Teramoto, Masahiro
Inoue, Takayuki
Okada, Masaya
Yoshihara, Kyoko
Tamaki, Hiroya
Yoshihara, Satoshi
Fujiwara, Hiroshi
TRANSPLANT IMMUNOLOGY, 2024, 87
[35] Impact of "day 90" CD4+T cells on clinical outcomes in children with relapsed/refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Yang, Jin
Lu, Qin
Jing, Wei
Ling, Jing
Li, Bohan
Gao, Wei
Cheng, Shengqin
Xiao, Peifang
Li, Jie
Shu, Guihua
Lu, Jun
Hu, Shaoyan
TRANSPLANT IMMUNOLOGY, 2024, 86
[36] Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation
Kochenderfer, James N.
Dudley, Mark E.
Carpenter, Robert O.
Kassim, Sadik H.
Rose, Jeremy J.
Telford, William
Hakim, Frances T.
Halverson, David
Fowler, Daniel H.
Hardy, Nancy M.
Mato, Anthony
Hickstein, Dennis D.
Gea-Banacloche, Juan
Pavletic, Steven Z.
Sportes, Claude
Maric, Irma
Feldman, Steven
Hansen, Brenna G.
Wilder, Jennifer
Blacklock-Schuver, Bazetta
Jena, Bipulendu
Bishop, Michael
Rosenberg, Steven A.
Gress, Ronald E.
BLOOD, 2013, 122 (21)
[37] Adoptively Transferred Donor-Derived Cytokine Induced Memory-like NK Cells Persist and Induce Remission in Pediatric Patient with Relapsed Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
Bednarski, Jeffrey J.
Zimmerman, Clare
Cashen, Amanda F.
Desai, Sweta
Foster, Mark
Schappe, Tim
McClain, Ethan
Becker-Hapak, Michelle
Berrien-Elliott, Melissa M.
Fehniger, Todd A.
BLOOD, 2019, 134
[38] GENERATION OF PATIENT-INDIVIDUALIZED AML-REACTIVE DONOR CD8+T CELLS UNDER GMP-COMPLIANT CONDITIONS FOR ADOPTIVE TRANSFER IN LEUKEMIA PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Chung-Ueck, B.
Frey, M.
Richter, A.
Haak, M.
Langeveld, K.
Busse, B.
Assenmacher, M.
Boenig, H.
Albrecht, J.
Herr, W.
Hartwig, U. F.
HAEMATOLOGICA, 2014, 99 : 439 - 440
[39] Effect of donor regulatory T-cells on CMV-specific CD8+T lymphocytes reconstitution and acute GvHD after allogeneic haematopoietic stem cell transplantation
Pastore, D.
Delia, M.
Mestice, A.
Carluccio, P.
Rossi, A. Russo
Ricco, A.
Giordano, A. M.
Cazzato, L.
Liso, V.
Specchia, G.
BONE MARROW TRANSPLANTATION, 2010, 45 : S127 - S127
[40] Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor
Nemeckova, Sarka
Alexova-Zurkova, Kamila
Hainz, Petr
Krystofova, Jitka
Mackova, Jana
Roubalova, Katerina
Stastna-Markova, Marketa
Vrana, Milena
Vydra, Jan
CURRENT ONCOLOGY, 2022, 29 (05) : 2928 - 2934

← 1 2 3 4 5 →